Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells

Journal of Controlled Release

Volumn 53, Issue 1-3, 1998, Pages 39-48

  Wang, Susan ^a   Low, Philip S ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Cancer cell targeting; Cancer chemotherapy; Folate receptor mediated endocytosis; Targeted imaging agents

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGODEOXYNUCLEOTIDE; CELL SURFACE RECEPTOR; CONTRAST MEDIUM; CYTOTOXIN; DEFEROXAMINE; FOLATE BINDING PROTEIN; FOLIC ACID; GALLIUM 67; LIPOSOME; NUCLEIC ACID; PENTETATE INDIUM IN 113M;

CANCER CELL; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CONFERENCE PAPER; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG SELECTIVITY; DRUG TARGETING; ELECTRON MICROSCOPY; ENDOCYTOSIS; GENE OVEREXPRESSION; GENE THERAPY; HUMAN; INTERNALIZATION; NONHUMAN; PH; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CARRIER PROTEINS; CONTRAST MEDIA; ENDOCYTOSIS; FOLIC ACID; GENE THERAPY; HUMANS; HYDROGEN-ION CONCENTRATION; MICROSCOPY, ELECTRON; NUCLEIC ACIDS; RECEPTORS, CELL SURFACE;

EID: 0032580526     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(97)00236-8     Document Type: Conference Paper

References (34)

1. Campbell I.G., Jones T.A., Foulkes W.D., Trowsdale J. Folate-binding protein is a marker for ovarian cancer, Cancer Res. 51:1991;5329-5338.
2. Coney L.R., Tomassetti A., Carayannopoulos L.et al. Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein. Cancer Res. 51:1991;6125-6132.
3. Franklin W.A., Waintrub M., Edwards D.et al. New anti-lung-cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinoma. Int. J. Cancer. 8(Suppl.):1994;89-95.
4. Garin-Chesa P., Campbell I., Saigo P., Lewis J., Old L., Rettig W. Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. Am. J. Pathol. 142:1993;557-567.
5. Holm J., Hansen S.I., Hoier-Madsen M., Sondergaard K., Bzorek M. Folate receptor of human mammary adenocarcinoma. APMIS. 102:1994;413-419.
6. Rettig W., Garin-Chesa P., Beresford H., Oettgen H., Melamed M., Old L. Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells. Proc. Natl. Acad. Sci. USA. 85:1988;3110-3114.
7. Ross J.F., Chaudhuri P.K., Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines -Physiologic and clinical implications. Cancer. 73:1994;2432-2443.
8. Weitman S.D., Lark R.H., Coney L.R.et al. Distribution of the folate receptor (GP38) in normal and malignant cell lines and tissues. Cancer Res. 52:1992;3396-3401.
9. Antony A.C., Kane M.A., Portillo R.M., Elwood P.C., Kolhouse J.F. Study of the role of a particulate folate-binding protein in the uptake of 5-methyltetrahydrofolate. J. Biol. Chem. 260:1985;14911-14917.
10. Kamen B.A., Capdevila A. Receptor-mediated folate accumulation is regulated by the cellular folate content. Proc. Natl. Acad. Sci. USA. 83:1986;5983-5987.
11. Leamon C.P., Low P.S. Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. Proc. Natl. Acad. Sci. USA. 88:1991;5572-5576.
12. Lee R.J., Low P.S. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J. Biol. Chem. 269:1994;3198-3204.
13. Leamon C.P., Low P.S. Membrane folate-binding proteins are responsible for folate-protein conjugate endocytosis into cultured cells. Biochem. J. 291:1993;855-860.
14. Lacey S.W., Sanders J.M., Rothberg K.G., Anderson R.G.W., Kamen B.A. cDNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol. J. Clin. Invest. 84:1989;715-720.
15. Turek J.J., Leamon C.P., Low P.S. Endocytosis of folate-protein conjugates: ultrastructural localization in KB cells. J. Cell Sci. 106:1993;423-430.
16. Anderson R.G.W., Kamen B.A., Rothberg K.G., Lacey S.W. Potocytosis: sequestration and transport of small molecules by caveolae. Science. 255:1992;410-411.
17. Lee R.J., Wang S., Low P.S. Measurement of Endosomal pH Following Folate Receptor-Mediated Endocytosis. Biochim. Biophys. Acta. 1312:1996;237-242.
18. Wang S., Lee R.J., Cauchon G., Gorenstein D.G., Low P.S. Delivery of antisense oligonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethyleneglycol. Proc. Natl. Acad. Sci. USA. 92:1995;3318-3322.
19. G.B. Henderson, Nutritional, pharmacological, and physiological aspects, in: R.L. Blakley, M. Whitehead (Eds.), Folates and Pterins, John Wiley and Sons, New York, NY, 1986, pp. 207-250.
20. Gates S.B., Mendelsohn L.G., Shackelford K.A.et al. Characterization of folate receptor from normal and neoplastic murine tissue: influence of dietary folate on folate receptor expression. Clin. Cancer Res. 2:1996;1135-1141.
21. Leamon C.P., Low P.S. Selective targeting of malignant cells with cytotoxin-folate conjugates. J. Drug Target. 2:1994;101-112.
22. Leamon C.P., Pastan I., Low P.S. Cytotoxicity of folate-pseudomonas exotoxin conjugates toward tumor cells: contribution of translocation domain. J. Biol. Chem. 268:1993;24847-24854.
23. Wang S., Lee R.J., Mathias C.J., Green M.A., Low P.S. Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine-folate, a potential radiopharmaceutical for tumor imaging. Bioconj. Chem. 7:1996;56-62.
24. Mathias C.J., Wang S., Lee R.J., Waters D.J., Low P.S., Green M.A. Tumor selective radiopharmaceutical targeting via receptor-mediated endocytosis: evaluation of a gallium-67 labeled deferoxamine-folate conjugate. J. Nucl. Med. 37:1996;1003-1008.
25. Mathias C.J., Wang S., Waters D.J., Low P.S., Green M.A. Ga-67 and In-111 labeled folate-chelate conjugates for targeting tumor-associated folate binding protein. J. Nucl. Med. 37:1996;347-348.
26. 111In-DTPA-Folate for Use as a Tumor-Targeted Radiopharmaceutical. Bioconj. Chem. 8:1997;673-679.
27. Lee R.J., Low P.S. Folate-mediated tumor cell targeting of doxorubicin in vitro. Biochim. Biophys. Acta. 1233:1995;134-144.
28. Lee R.J., Huang L. Folate-targeted, anionic liposome-encapsulated polylysine-condensed DNA for tumor cell-specific gene transfer. J. Biol. Chem. 271:1996;8481-8487.
29. Gottschalk S., Cristiano R.J., Smith L.C., Woo S.L. Folate receptor-mediated DNA delivery into tumor cells: potosomal disruption results in enhanced gene expression. Gene Ther. 1:1994;185-191.
30. Subbarao N.K., Parente R.A., Szoka F.C. jr., Nadasdi L., Pongracz K. pH-dependent bilayer destabilization by an amphipathic peptide. Biochem. 26:1987;2964-2972.
31. Chu C.J., Szoka F.C. jr. pH-sensitive liposomes. J. Liposome Res. 4:1994;361-395.
32. Collins D., Litzinger D.C., Huang L. Structural and functional comparison of pH-sensitive liposomes composed of phosphatidylethanolamine and three different diacylsuccinylglycerols. Biochim. Biophys. Acta. 1025:1990;234-242.
33. Vogel K., Wang S., Lee R.J., Chmielewski J., Low P.S. Peptide-mediated release of folate-targeted liposome contents from endosomal compartments. J. Am. Chem. Soc. 118:1996;1581-1586.
34. Anderson V.C., Thompson D.H. Triggered release of hydrophilic agents from plasmalogen liposomes using visible light or acid. Biochim. Biophys. Acta. 1109:1992;33-42.